cysteine has been researched along with Cirrhosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, IM; Samynathan, R; Shariati, MA; Subramanian, U; Thiruvengadam, M; Venkidasamy, B | 1 |
| Huang, C; Luo, H; Luo, Y; Wu, H; Zhang, Y | 1 |
| Cao, N; Chen, Z; Guo, Y; Ji, X; Lei, Y; Li, B; Lin, J; Liu, Z; Mai, B; Meng, Y; Qiu, Y; Song, M; Tong, T; Wang, L; Wang, Q; Wei, Y; Wu, J; Xie, S; You, X | 1 |
| Bai, Y; Bian, X; He, P; Sun, G; Wu, Y; Yu, R; Zhang, B; Zhang, Y | 1 |
| Chang, L; Dai, T; Jia, W; Le, VM; Mao, Y; Rose, P; Tan, B; Tran, BH; Wang, Z; Xiong, Y; Yu, Y; Zhang, W; Zhong, R; Zhu, YZ | 1 |
| Chen, R; Li, XZ; Sohawon, Y; Tong, MQ; Wang, LF; Xiao, J; Xu, HL; Yao, Q; Zhao, YZ | 1 |
| Formica, C; Happé, H; McNeill, H; Peters, DJ; Scharpfenecker, M; Veraar, KA; Vortkamp, A | 1 |
| Huang, C; Kan, J; Liu, X; Ma, F; Tran, BH; Wang, S; Zhu, YZ; Zou, Y | 1 |
| Ago, T; Fu, C; Kuroda, J; Li, H; Pain, J; Sadoshima, J | 1 |
| Aesif, SW; Anathy, V; Budd, RC; Guala, AS; Janssen-Heininger, YM; Reiss, JN; Reynaert, NL; Roberson, EC; van der Velden, J | 1 |
| Dai, W; Guo, C; He, S; Hu, G; Ni, J; Shen, J; Wan, R; Wang, F; Wang, X; Xiong, J; Xu, L; Yang, L | 1 |
| Hagiwara, H; Hagiwara, K; Hirose, S; Ohtsuji, M; Ohtsuji, N; Shirai, N; Tomisawa, H | 1 |
| Dibello, PM; Handy, DE; Jacobsen, DW; Joseph, J; Loscalzo, J; Luptak, I; Metes-Kosik, N; Qin, F; Tang, SS; Zhi, H | 1 |
| Dafforn, TR; Foreman, RC; Lomas, DA; Mahadeva, R; Parfrey, H; Ravenhill, NA; Zhou, A | 1 |
| Yamada, G | 1 |
| Cheng, X; Cho, EA; Dressler, GR; Levitan, I; Lin, J; Park, JM; Patel, SR; Phan, SH; Ullenbruch, M | 1 |
| Chiang, PF; Hsu, CC; Wu, WJ; Yin, MC | 1 |
| Kumaran, C; Shivakumar, K | 1 |
| Gon, Y; Hashimoto, S; Horie, T; Masutani, H; Matsumoto, K; Nishiyama, A; Yodoi, J | 1 |
2 review(s) available for cysteine and Cirrhosis
| Article | Year |
|---|---|
Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease.
Topics: Animals; Apoptosis; Catalytic Domain; Cysteine; Fibrosis; Glutathione; Humans; Lung Diseases; Oxidation-Reduction; Signal Transduction | 2010 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
17 other study(ies) available for cysteine and Cirrhosis
| Article | Year |
|---|---|
S-Allylcysteine (SAC) Exerts Renoprotective Effects via Regulation of TGF- β1/Smad3 Pathway Mediated Matrix Remodeling in Chronic Renal Failure.
Topics: Adenine; Aged; Animals; Cysteine; Fibrosis; Humans; Kidney Failure, Chronic; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Smad Proteins; Smad3 Protein; Transforming Growth Factor beta1 | 2022 |
Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61.
Topics: Activating Transcription Factor 3; Angiogenic Proteins; Angiotensin II; Cyclic AMP Response Element-Binding Protein; Cysteine; Cysteine-Rich Protein 61; Fibrosis; Humans; Myocytes, Cardiac; RNA, Messenger; Transforming Growth Factor beta | 2022 |
Cysteine-Based Redox-Responsive Nanoparticles for Fibroblast-Targeted Drug Delivery in the Treatment of Myocardial Infarction.
Topics: Animals; Cysteine; Disease Models, Animal; Fibroblasts; Fibrosis; Mice; Myocardial Infarction; Myocardium | 2023 |
LIM and Cysteine-Rich Domains 1 Promotes Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition in Human Kidney 2 Cells.
Topics: Animals; Cysteine; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney; LIM Domain Proteins; Mice; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ubiquitin-Protein Ligases; Ureteral Obstruction | 2023 |
A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cystathionine gamma-Lyase; Cysteine; Disease Models, Animal; Fibrosis; Heart Failure; Hydrogen Sulfide; Liposomes; Male; Myocardium; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2019 |
Thiolated γ-polyglutamic acid as a bioadhesive hydrogel-forming material: evaluation of gelation, bioadhesive properties and sustained release of KGF in the repair of injured corneas.
Topics: Adhesiveness; Animals; Apoptosis; Cell Proliferation; Corneal Injuries; Cysteine; Delayed-Action Preparations; Drug Carriers; Fibroblast Growth Factor 7; Fibrosis; Hydrogels; Mice; Neovascularization, Pathologic; NIH 3T3 Cells; Polyglutamic Acid | 2019 |
Four-jointed knock-out delays renal failure in an ADPKD model with kidney injury.
Topics: Acute Kidney Injury; Animals; Cysteine; Disease Models, Animal; Disease Progression; Fibrosis; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Failure, Chronic; Male; Mice, Knockout; Mutation; Polycystic Kidney, Autosomal Dominant; Time Factors; TRPP Cation Channels; Wnt Signaling Pathway | 2019 |
Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cysteine; Delayed-Action Preparations; Disease Models, Animal; Fibrosis; Heart Failure; Heart Ventricles; Hydrogen Sulfide; Male; Oxidative Stress; Rats | 2013 |
Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.
Topics: Aconitate Hydratase; Aging; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Cells, Cultured; Cysteine; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Genotype; Humans; Mice; Mice, Transgenic; Mitochondria, Heart; Myocytes, Cardiac; NADH Dehydrogenase; NADPH Oxidase 4; NADPH Oxidases; Onium Compounds; Oxidation-Reduction; Oxidative Stress; Phenotype; Rats; Rats, Wistar; Rotenone; Superoxides; Transfection; Uncoupling Agents; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
L-cysteine administration attenuates pancreatic fibrosis induced by TNBS in rats by inhibiting the activation of pancreatic stellate cell.
Topics: Animals; Cysteine; Fibrosis; Pancreatic Diseases; Pancreatic Stellate Cells; Pancreatitis, Chronic; Rats; Treatment Outcome; Trinitrobenzenesulfonic Acid | 2012 |
Nephrotoxic effect of subchronic exposure to S-(1,2-dichlorovinyl)-L-cysteine in mice.
Topics: Animals; Blood Urea Nitrogen; Cyclooxygenase 2; Cysteine; Fibrosis; Interleukin-6; Kidney; Male; Mice; Mice, Inbred BALB C; Necrosis; Organ Size; RNA, Messenger; Tumor Necrosis Factor-alpha | 2012 |
Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance.
Topics: Animals; Cardiomyopathies; Cysteine; Diet; Dietary Supplements; DNA Methylation; Epigenomics; Fibrosis; Glutathione; Homocysteine; Isoprostanes; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Real-Time Polymerase Chain Reaction; Selenium; Selenoproteins | 2012 |
Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease.
Topics: alpha 1-Antitrypsin; Animals; Binding Sites; Carcinoma, Hepatocellular; Chymotrypsin; Crystallography, X-Ray; Cysteine; Fibrosis; Glycine; Hepatitis; Hepatocytes; Hydrogen-Ion Concentration; Models, Molecular; Mutation; Oocytes; Phenylalanine; Polymers; Potassium Chloride; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Temperature; Threonine; Time Factors; Xenopus | 2003 |
Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Cysteine; DNA-Binding Proteins; Eye Proteins; Fibrosis; Kidney; Mice; Mutation; Nerve Tissue Proteins; NIH 3T3 Cells; Protein Structure, Tertiary; Proteins; Sequence Alignment; Signal Transduction; Smad Proteins; Smad1 Protein; Trans-Activators; Xenopus Proteins | 2005 |
Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Cysteine; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drinking; Fibrosis; Glutathione; Kidney; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Weight Loss | 2007 |
Superoxide-mediated activation of cardiac fibroblasts by serum factors in hypomagnesemia.
Topics: Animals; Cell Division; Collagen; Cysteine; Fibroblasts; Fibrosis; Magnesium Deficiency; Myocardium; Plasma; Rats; Receptors, Neurokinin-1; Superoxide Dismutase; Superoxides | 2001 |
C-propeptide region of human pro alpha 1 type 1 collagen interacts with thioredoxin.
Topics: Binding Sites; Cell Line; Collagen; Collagen Type I; Cysteine; DNA, Complementary; Dose-Response Relationship, Drug; Fibrosis; Gene Library; Glutathione; Humans; Hydrogen Peroxide; Lung; Oxidation-Reduction; Oxidative Stress; Peptides; Plasmids; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Thioredoxins; Two-Hybrid System Techniques | 2002 |